| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/05/2022 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 11/30/2022 | 17.74% | B of A Securities | → $22 | Initiates Coverage On | → Buy |
| 11/22/2022 | 12.39% | Oppenheimer | → $21 | Initiates Coverage On | → Outperform |
| 11/22/2022 | 7.04% | Goldman Sachs | → $20 | Initiates Coverage On | → Neutral |
| 11/21/2022 | 44.5% | Vertical Research | → $27 | Initiates Coverage On | → Buy |
| 11/10/2022 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 11/04/2022 | 7.04% | Stifel | → $20 | Initiates Coverage On | → Buy |
What is the target price for RXO (RXO)?
The latest price target for RXO (NYSE: RXO) was reported by Raymond James on December 5, 2022. The analyst firm set a price target for $0.00 expecting RXO to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for RXO (RXO)?
The latest analyst rating for RXO (NYSE: RXO) was provided by Raymond James, and RXO initiated their market perform rating.
When is the next analyst rating going to be posted or updated for RXO (RXO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RXO, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RXO was filed on December 5, 2022 so you should expect the next rating to be made available sometime around December 5, 2023.
Is the Analyst Rating RXO (RXO) correct?
While ratings are subjective and will change, the latest RXO (RXO) rating was a initiated with a price target of $0.00 to $0.00. The current price RXO (RXO) is trading at is $18.68, which is out of the analyst's predicted range.